GW Pharmaceuticals Plc (GWPH)

168.61
0.71 0.42
NASDAQ : Health Technology
Prev Close 169.32
Open 171.33
Day Low/High 166.69 / 172.96
52 Wk Low/High 90.14 / 179.65
Volume 282.21K
Avg Volume 519.70K
Exchange NASDAQ
Shares Outstanding 30.45M
Market Cap 5.16B
EPS -10.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
GW Pharmaceuticals (GWPH) Stock Soars on Positive Trial Results, Piper Jaffray Bullish

GW Pharmaceuticals (GWPH) Stock Soars on Positive Trial Results, Piper Jaffray Bullish

GW Pharmaceuticals (GWPH) said on Monday its seizure drug epidiolex had positive results in a late-stage clinical trial.

Stephen King's Maximum Oversold (by Midweek)

And we'll get FOMC and BoJ then.

'Mad Money' Lightning Round: Abbvie Is a Great Long-Term Position

'Mad Money' Lightning Round: Abbvie Is a Great Long-Term Position

Cramer is sticking with International Paper and likes Advanced Micro Devices.

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

This is not the time to sell in a panic, Cramer says.

4 Companies Likely to Benefit From Widening Legalization of Marijuana

4 Companies Likely to Benefit From Widening Legalization of Marijuana

The marijuana market is heating up as marijuana usage for medical and recreational purposes gains legitimacy.

GW Pharmaceuticals (GWPH) Closed Higher on Takeover Speculation

GW Pharmaceuticals (GWPH) Closed Higher on Takeover Speculation

GW Pharmaceuticals (GWPH) reportedly hired Morgan Stanley after it was approached by several companies about a possible takeover.

'Mad Money' Lightning Round: Weight Watchers Is Not for Me

'Mad Money' Lightning Round: Weight Watchers Is Not for Me

Cramer says sell Stryker and buy Zimmer Biomet, and take Randgold over Barrick Gold.

Jim Cramer's 'Mad Money' Recap: I Can't Figure Out the Consumer

Jim Cramer's 'Mad Money' Recap: I Can't Figure Out the Consumer

The economy needs consumers to buy, buy, buy but so far consumers have been all over the map, Cramer says.

Why Nasdaq-Traded Marijuana Stocks Remain Undervalued

Why Nasdaq-Traded Marijuana Stocks Remain Undervalued

Nasdaq-traded marijuana stocks are undervalued as investors remain skittish and the use of drugs produced by these biopharmaceutical companies have not been widely adopted.

Consumer Staples And Utilities Sectors Avoided Volatility in Brexit Aftermath

Consumer Staples And Utilities Sectors Avoided Volatility in Brexit Aftermath

Investors should stick with buying stocks in the utilities and consumer staples sectors, which rose higher in the aftermath of the Brexit vote and avoided the massive volatility.

Janney Says Sell GW Pharma Despite Marijuana-Derived Drug Success In Seizures

Janney Says Sell GW Pharma Despite Marijuana-Derived Drug Success In Seizures

Shares of GW Pharmaceuticals are on the rise after the company announced this morning positive Phase 3 results for its Epidiolex for the treatment of Lennox-Gastaut syndrome, or LGS.

GW Pharmaceuticals (GWPH) Moving On Heavy Volume In The Pre-Market Hours

GW Pharmaceuticals (GWPH) Moving On Heavy Volume In The Pre-Market Hours

Trade-Ideas LLC identified GW Pharmaceuticals (GWPH) as a pre-market mover with heavy volume candidate

GW Pharma Marijuana Drug Confirms Seizure Benefit in Second Pivotal Trial

GW Pharma Marijuana Drug Confirms Seizure Benefit in Second Pivotal Trial

GW Pharmaceuticals announced positive results Monday from a second, pivotal clinical trial involving children with a severe form of epilepsy treated with its experimental marijuana-based drug.

Brexit Vote Leaves Investors Cautious

Folks are anxious, dying to be bullish yet also curbing their enthusiasm.

Here’s How You Should Invest If Gary Johnson Makes It to the White House

Here’s How You Should Invest If Gary Johnson Makes It to the White House

It may not be the likeliest of scenarios, but if Gary Johnson becomes president of the United States, investors might want to shift some money around. Here's how.

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

'Brexit' will be Cramer's focus, along with company earnings and Fed Chair Janet Yellen's congressional testimony.

'Mad Money' Lightning Round: Buy, Buy, Buy Edward Lifesciences

'Mad Money' Lightning Round: Buy, Buy, Buy Edward Lifesciences

Cramer says American Tower is a buy and is hesitant on B&G Foods.

Economics of Pot: The Problems With Investing in Marijuana

Economics of Pot: The Problems With Investing in Marijuana

As more states consider legalizing the drug for recreational use, forward-thinking investors are wondering how to profit.

'Mad Money' Lightning Round: Buy, Buy, Buy Intuit

'Mad Money' Lightning Round: Buy, Buy, Buy Intuit

Cramer says Time Warner is a good stock but you should sell Interoil.

Jim Cramer's 'Mad Money' Recap: Stay Disciplined in This Market

Jim Cramer's 'Mad Money' Recap: Stay Disciplined in This Market

How does Cramer know that investors are getting careless? Because they see takeovers everywhere.

TheStreet Quant Rating: D (Sell)